PlexusDx vs AltRx: GLP-1 Pricing and Plan Terms Compared for 2026

Last reviewed: September 8, 2026 Last updated: September 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

AltRx advertised promotional pricing for compounded semaglutide and tirzepatide that expired September 5, 2026. During that promotion, AltRx's monthly semaglutide rate was advertised at $89/month and its 12-month prepaid semaglutide rate at $75/month ($900 upfront)—well below PlexusDx's $189/month month-to-month and $149/month six-month rates. Standard post-promotion pricing for AltRx is not documented in available sources as of this writing (September 8, 2026). Additionally, individual customer reports on Trustpilot and Reddit allege billing for full annual amounts despite selecting month-to-month plans, creating a conflict with AltRx's advertised "cancel anytime" claim. PlexusDx operates month-to-month with no prepayment requirement at any commitment tier, holds a 4.3-star Trustpilot rating (79% five-star, 83% four stars or higher; captured September 9, 2026), charges no membership fee, and includes medication, licensed provider review, and shipping in a single all-inclusive price. If AltRx's promotional pricing has been extended or replaced, confirm current rates and cancellation terms at checkout before committing to any prepaid plan.

At-a-glance comparison: AltRx vs PlexusDx

AltRx pricing captured September 4, 2026; PlexusDx pricing captured September 8, 2026. All AltRx figures are time-limited promotional rates that expired September 5, 2026. Post-promotion standard rates are not documented in available sources.

Normalized 12-month cost: AltRx vs PlexusDx

The tables below show total 12-month spending and effective monthly rates under each plan tier. AltRx figures reflect the expired promotional pricing captured before September 5, 2026; standard ongoing rates after that date are unknown. PlexusDx figures are current as of September 8, 2026. All prepaid equivalents and annual totals are our calculation.

Compounded semaglutide injection

Compounded tirzepatide injection

Key observation: AltRx's advertised promotional pricing—active until September 5, 2026—delivered meaningfully lower annual costs across all tiers and both compounds, with the steepest discounts at the 12-month prepaid level ($900/year for semaglutide, $1,500/year for tirzepatide). Those promotional rates required full upfront payment for multi-month commitments, and post-promotion standard rates are not available in the evidence. Confirm current pricing and prepayment requirements at checkout.

AltRx promotional pricing and post-promotion uncertainty

Every AltRx price figure in this comparison was captured from the provider's website on September 4, 2026, two days before the advertised promotional deadline of September 5, 2026. Sources documented the promotion's end date but did not specify what standard pricing would apply afterward. As of this article's publication (September 8, 2026), post-promotion rates are not available in the evidence.

If you are evaluating AltRx after the promotional period, confirm current pricing, prepayment requirements, and cancellation terms directly at checkout. The promotional rates shown here may no longer be available, and standard ongoing rates may differ materially.

Prepayment structure: upfront cash vs month-to-month flexibility

AltRx's multi-month tiers—during the documented promotional period—required full upfront payment: $255 every three months for semaglutide at the 3-month rate, $480 every six months at the 6-month rate, and $900 for a full year at the 12-month rate. Tirzepatide followed the same structure at higher dollar amounts ($432 quarterly, $780 semi-annually, $1,500 annually). That prepayment delivered the lowest per-month rates but tied up capital and locked in commitment.

PlexusDx operates without prepayment at any tier. The $189 month-to-month semaglutide rate bills monthly; the $169 three-month rate bills monthly; the $149 six-month rate bills monthly. You carry a commitment to stay for the term you select, but you never prepay the full amount. The same applies to all PlexusDx formulations—tirzepatide injection, oral semaglutide, oral tirzepatide, and the microdose maintenance protocol—across every commitment tier.

Cancellation terms and customer billing reports

AltRx's website advertised "cancel anytime" during the captured promotional period (September 4, 2026). However, individual customer reports on Trustpilot and Reddit allege being charged for a full annual subscription despite selecting month-to-month plans. One Trustpilot 1-star review described "a full annual prebill despite selecting month-to-month," and similar allegations appeared in a Reddit thread captured on the same date. These are individual reports—allegations, not verified facts—but they create a material conflict with the advertised cancellation claim.

If you select AltRx, clarify billing and cancellation mechanics at checkout, retain confirmation of your selected plan term, and monitor your payment method for unexpected charges. If you select a prepaid multi-month plan, understand that the upfront payment is non-refundable under typical subscription terms (confirm the provider's specific refund policy).

PlexusDx bills month-to-month at all tiers with no upfront lump sum. You commit to a term (one, three, or six months), and you may cancel subject to that term, but no single charge exceeds one month's cost.

Product range and formulation options

AltRx offers compounded semaglutide and tirzepatide injections at the promotional rates documented here, and sources note that Zepbound, Wegovy, and Ozempic are also listed on the site. Pricing, availability, and insurance handling for branded medications are not documented in the evidence.

PlexusDx offers five compounded GLP-1 protocols:

• Semaglutide injection: $189/month (MTM), $169/month (3-month), $149/month (6-month)
• Tirzepatide injection: $289/month (MTM), $269/month (3-month), $249/month (6-month)
• Semaglutide oral: $289/month (MTM), $269/month (3-month), $249/month (6-month)
• Tirzepatide oral: $349/month (MTM), $299/month (3-month), $279/month (6-month)
• Microdose GLP-1 (maintenance): $129/month (MTM only)

All PlexusDx protocols include medication, licensed provider review, and shipping in the published price, with no separate membership fee. Same price at every dose for any given medication and route.

Review record and service transparency

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). The provider publishes its dosing protocols, ingredient sourcing practices, and pharmacy partnership model (licensed 503A compounding pharmacies) on its website.

AltRx's Trustpilot rating, review volume, and customer support themes are not documented in the evidence. The billing-practice allegations described above are the only captured service-quality datapoints, and they represent individual customer reports rather than a pattern confirmed across a representative sample.

Choose AltRx if…

• The promotional pricing documented here (expired September 5, 2026) has been extended or replaced with comparable rates, and you have confirmed current pricing and terms at checkout.
• You are comfortable prepaying $480 to $1,500 upfront for a six- or twelve-month supply to lock in the lowest per-month rate, and you have verified the provider's refund policy for prepaid commitments.
• You prefer a provider that offers both compounded and branded GLP-1 options under one account (branded availability and pricing not documented here).
• You have reviewed recent customer feedback on billing practices and cancellation handling and are satisfied with the provider's current terms.

Choose PlexusDx if…

• You want month-to-month billing with no upfront lump-sum payment, even at longer commitment tiers, so your cash flow remains predictable.
• You value a 4.3-star Trustpilot rating with a verified positive-review majority (79% five-star, 83% four stars or higher).
• You want access to oral semaglutide or tirzepatide formulations for needle-free administration, or a microdose maintenance protocol for long-term weight stability.
• You prefer a provider that publishes its pharmacy partnership model (licensed 503A compounders), ingredient sourcing, and dosing protocols transparently on its website.
• You want the option to adjust your commitment tier or pause treatment without navigating prepaid-refund disputes.

Methodology and freshness

AltRx pricing and terms were captured from the provider's website on September 4, 2026, at 13:49:55 UTC. All AltRx figures reflect time-limited promotional pricing advertised to expire September 5, 2026; standard post-promotion rates are not documented. PlexusDx pricing was captured September 8, 2026, from live product pages and internal pricing tables. Trustpilot ratings and review distributions were captured September 4, 2026, for PlexusDx; AltRx's rating was not documented. Customer billing reports were paraphrased from Trustpilot and Reddit threads captured September 4, 2026, and represent individual allegations rather than verified facts or systematic patterns. All 12-month cost calculations and prepaid per-month equivalents are our calculation. We recommend confirming all pricing, prepayment terms, cancellation policies, and current promotional status at checkout before committing to any plan.

Frequently Asked Questions

Did AltRx's promotional pricing end on September 5, 2026?

Sources documented that AltRx's promotional rates were advertised to end September 5, 2026. This article was published September 8, 2026, and post-promotion standard pricing is not available in the evidence. Confirm current rates and terms directly with AltRx before selecting a plan.

Does PlexusDx require prepayment for multi-month commitments?

No. PlexusDx bills month-to-month at all commitment tiers—one-month, three-month, and six-month. You commit to stay for the term you select, but no single charge exceeds one month's cost. You never prepay a lump sum for a quarter, half-year, or full year.

What do the billing-practice reports about AltRx mean for someone selecting a plan?

Individual customers reported on Trustpilot and Reddit that they were charged for a full year despite selecting month-to-month plans. These are allegations, not verified facts. If you choose AltRx, clarify billing and cancellation terms at checkout, retain confirmation of your selected plan, and monitor your payment method for unexpected charges.

Can I switch from AltRx to PlexusDx mid-treatment?

Switching telehealth GLP-1 providers mid-treatment is possible in principle, but each provider's clinician must independently evaluate your history, current dose, and medical appropriateness. Neither provider guarantees acceptance of transfer patients, continuation at your current dose, or uninterrupted medication supply. Plan any transition with enough lead time to avoid a gap.

Which provider offers the lowest total cost over 12 months?

AltRx's documented promotional pricing—active until September 5, 2026—delivered the lowest 12-month cost for both semaglutide ($900/year at the 12-month prepaid tier) and tirzepatide ($1,500/year at the 12-month prepaid tier). Those rates required full upfront payment and have since expired; post-promotion rates are unknown. PlexusDx's current six-month semaglutide rate is $1,788/year with no prepayment required.

Sources

• PlexusDx product pages and pricing tables (captured September 8, 2026)
• AltRx website promotional pricing and plan terms (captured September 4, 2026, 13:49:55 UTC)
• Trustpilot reviews for PlexusDx (captured September 4, 2026)
• Trustpilot and Reddit customer reports regarding AltRx billing practices (captured September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.